This review highlights the thromboembolic risks of cardioversion, the necessity of rate control for rapid ventricular rates, and the high mortality associated with atrial fibrillation during acute myocardial infarction.
Multiple agents allow flexible atrial fibrillation management; leaves open optimal selection and mortality reduction in acute myocardial infarction.
Atrial fibrillation is a common tachyarrhythmia. Cardioversion either electrically or pharmacologically carries the risk of thromboembolism. All patients with resting ventricular rates greater than 140/min require rate control. Many drugs are effective in either slowing and or reverting atrial fibrillation but no one drug appears superior. Atrial fibrillation in the setting of acute myocardial infarction is associated with a high mortality.
No takes yet. Share an insight, caveat, or question.
Karen Richards (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: